Ultrapetrol Announces Expansion of Board of Directors
Mar 07, 2016 21:15 pm UTC| Business
NASSAU, Bahamas, March 07, 2016 -- Ultrapetrol (Bahamas) Limited(Nasdaq:ULTR), an industrial transportation company serving marine transportation needs in three markets (River Business, Offshore Supply Business, and...
Otonomy Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update
Mar 07, 2016 21:14 pm UTC| Business
SAN DIEGO, March 07, 2016 -- Otonomy, Inc.(NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today reported...
Nivalis Therapeutics Expands N91115 Clinical Development Program in Cystic Fibrosis
Mar 07, 2016 21:05 pm UTC| Business
Higher-dose arm initiated in ongoing Phase 2 study following safety review by independentData Monitoring Committee New Phase 2 study planned for patients who have one copy of the F508del-mutation and a second gating...
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
Mar 07, 2016 21:05 pm UTC| Business
TUSTIN, Calif., March 07, 2016 -- Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) (Nasdaq:PPHMP) today announced that its Board of Directors has declared a quarterly cash dividend payment on the Company's 10.50% Series E...
EyeGate Pharma Acquires Jade Therapeutics
Mar 07, 2016 21:05 pm UTC| Business
Transaction enhances development pipeline with addition of new ophthalmic platform technology. First Jade product to enter clinic later this year.WALTHAM, Mass., March 07, 2016 -- Eyegate Pharmaceuticals, Inc....
Newtek Business Services Corp. Reports Full Year 2015 Financial Results
Mar 07, 2016 21:05 pm UTC| Business
NEW YORK, March 07, 2016 -- Newtek Business Services Corp. (“Newtek” or the “Company”), (NASDAQ:NEWT), an internally managed business development company (“BDC”), announced today its financial results for the year ended...
Aduro Biotech to Present at ROTH Conference
Mar 07, 2016 21:05 pm UTC| Business
BERKELEY, Calif., March 07, 2016 -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the 28th Annual ROTH Conference in...